Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis.

Giorgio Walter CanonicaTim W HarrisonPascal ChanezFrancesco MenzellaRenaud LouisBorja García CosioNjira L LugogoArjun MohanAnnie BurdenEsther Garcia Gil

Published in: Allergy (2021)

These substudy data from ANDHI demonstrated the efficacy profile of benralizumab for patients with severe, eosinophilic asthma and NP, with improvement in SNOT-22 and asthma outcomes.

Keyphrases

chronic rhinosinusitis
chronic obstructive pulmonary disease
lung function
allergic rhinitis
early onset
electronic health record
type diabetes
big data
machine learning
cystic fibrosis
metabolic syndrome
adipose tissue
deep learning
sleep quality